Pixium Vision announces peer-reviewed publications demonstrating the potential of the Next Generation PRIMA implant to restore vision at five times higher resolution than current implant
January 12, 2023 01:00 ET
|
Pixium Vision
Pixium Vision announces peer-reviewed publications demonstrating the potential of the Next Generation PRIMA implant to restore vision at five times higher resolution than current implant New...
Pixium Vision accueille favorablement le jugement du Tribunal de commerce de Paris contre Second Sight Medical Products
December 28, 2022 01:00 ET
|
Pixium Vision
Pixium Vision accueille favorablement le jugement du Tribunal de commerce de Paris contre Second Sight Medical Products Le Tribunal a conclu que Second Sight Medical Products a violé ses obligations...
Pixium Vision welcomes judgment by Paris Commercial Court against Second Sight Medical Products
December 28, 2022 01:00 ET
|
Pixium Vision
Pixium Vision welcomes judgment by Paris Commercial Court against Second Sight Medical Products Court finds Second Sight Medical Products breached 2021 contractual obligations to Pixium VisionCourt...
Pixium Vision annonce avoir finalisé les implantations de son étude pivot européenne PRIMAvera et confirme l’annonce des résultats d’ici à la fin 2023 ainsi que la soumission réglementaire en Europe au premier semestre 2024
December 15, 2022 01:00 ET
|
Pixium Vision
Pixium Vision annonce avoir finalisé les implantations de son étude pivot européenne PRIMAvera et confirme l’annonce des résultats d’ici à la fin 2023 ainsi que la soumission réglementaire en Europe...
Pixium Vision announces completion of implantations in the European pivotal trial PRIMAvera and confirms target read-out around the end of 2023 and regulatory submission in Europe in H1 2024
December 15, 2022 01:00 ET
|
Pixium Vision
Pixium Vision announces completion of implantations in the European pivotal trial PRIMAvera and confirms target read-out around the end of 2023 and regulatory submission in Europe in H1 2024 38...
Pixium Vision annonce sa participation à plusieurs conférences et événements destinés aux investisseurs en novembre et décembre 2022
November 15, 2022 01:00 ET
|
Pixium Vision
Pixium Vision annonce sa participation à plusieurs conférences et événements destinés aux investisseurs en novembre et décembre 2022 Paris, France, 15 novembre 2022 - 07h00 CET - Pixium Vision SA...
Pixium Vision announces participation in investor conferences in November and December 2022
November 15, 2022 01:00 ET
|
Pixium Vision
Pixium Vision announces participation in investor conferences in November and December 2022 Paris, France, November 15, 2022 – 07:00 CET – Pixium Vision SA (Euronext Growth Paris - FR0011950641;...
Pixium Vision annonce sa position de trésorerie au 30 septembre 2022 et fait le point sur ses activités
October 21, 2022 01:00 ET
|
Pixium Vision
Pixium Vision annonce sa position de trésorerie au 30 septembre 2022 et fait le point sur ses activités Paris, 21 octobre 2022 – 7 h 00 CET – Pixium Vision SA (Euronext Growth Paris...
Pixium Vision announces its cash position at 30 September 2022 and provides an update on its activities
October 21, 2022 01:00 ET
|
Pixium Vision
Pixium Vision announces its cash position at 30 September 2022 and provides an update on its activities Paris, 21 October 2022 – 07:00 CET – Pixium Vision SA (Euronext Growth Paris -...
Pixium Vision announces the publication of peer-reviewed clinical data of the Prima System in Dry AMD in the Journal of Neural Engineering
October 11, 2022 01:00 ET
|
Pixium Vision
Pixium Vision announces the publication of peer-reviewed clinical data of the Prima System in Dry AMD in the Journal of Neural Engineering Distance between the implant and the target cells was stable...